Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative therapies function by mimicking the inherent actions of GLP-1, a hormone released by https://rotatesites.com/story22266436/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes